METTL3 and central nervous system cancer: Some bioinformatics studies have also revealed that high expression of METTL3 in glioma tissues can activate multiple oncogenic pathways and upregulate the expression of oncogenic factors, including those in the Notch pathway and NOTCH3, thereby promoting the onset of gliomas (73).